Akademisyen
ENİS ÖZYAR
PROFESÖR
ACIBADEM MEHMET ALİ AYDINLAR ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Radyasyon Onkolojisi
Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.
- Makale 32
- Proje 0
- Kitap 0
- Bildiri 6
- Patent 0
- Sanatsal 0
Scopus (SJR)
Q1
14
Q2
1
Q3
1
Q4
1
WoS (JCR)
Q1
11
Q2
3
Q3
2
Q4
2
TR Index
1
makale
Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.
Üst %1 makale
0
Üst %10 makale
3
Ort. yüzdelik
60.0%
Üst %1 payı
0.0%
Üst %10 payı
18.8%
Makaleler
YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.
Makale listesi
- 2021 Time Analysis of Online Adaptive Magnetic Resonance\u2013Guided Radiation Therapy Workflow According to Anatomical Sites YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 98.7%
- 2020 Multichannel Film Dosimetry for Quality Assurance of Intensity Modulated Radiotherapy Treatment Plans Under 0.35 T Magnetic Field YÖKSİS JCR Q3 OpenAlex 80.7%
- 2018 Treatment outcome and prognostic factors for adult patients with medulloblastoma: The Rare Cancer Network (RCN) experience YÖKSİS SJR Q1 JCR Q1 OpenAlex 89.3%
- 2018 Medically Inoperable Early-Stage Lung Cancer Treated with Stereotactic Ablative Radiation Therapy (SABR): Multicenter Study of Turkish Radiation Oncology Group (TROG) YÖKSİS SJR Q1 JCR Q1 OpenAlex 17.6%
- 2017 Serviks Kanserinde Türkiye’deki Sağkalım: 16 Merkezin Ortak Sonuçları YÖKSİS
- 2017 Concurrent Cisplatin and Radiotherapy Versus Cetuximab and Radiotherapy, an Unsolved Problem. YÖKSİS SJR Q1 JCR Q1
- 2017 Serviks Kanser,nde Türkiye’xxdeki sağkalım Sonuçları YÖKSİS
- 2017 Serviks Kanserinde Türkiyedeki Sağkalım: 16 Merkezin ortak sonuçları YÖKSİS TR Index SJR Q4 JCR Q4
- 2012 Stereotactic Radiotherapy of Primary Lung Cancer and Other Targets Results of Consultant Meeting of the International Atomic Energy Agency Int J Radiat Oncol Biol Phys 2011 79 660 669 YÖKSİS SJR Q1 JCR Q1 OpenAlex 15.6%
- 2008 Effect of Bladder Distension on Dose Distribution of Intracavitary Brachytherapy for Cervical Cancer Three Dimensional Computed Tomography Plan Evaluation YÖKSİS SJR Q1 JCR Q1 OpenAlex 80.9%
- 2008 Retrospective Analysis of 271 Patients with T1N0M0 Glottic Laryngeal Cancer YÖKSİS SJR Q1 JCR Q1 OpenAlex 14.9%
- 2007 Long term outcome and prognostic factors in patients with cervical carcinoma a retrospective study YÖKSİS SJR Q1 JCR Q3 OpenAlex üst %10 OpenAlex 90.6%
- 2007 5504 ORAL Quantification of plasma Epstein Barr virus DNA in patients with nasopharyngeal carcinoma results of a prospective study YÖKSİS SJR Q3 JCR Q2
- 2006 Relapse Pattern of GOG 122 Trial Should Be More Informative YÖKSİS SJR Q1 JCR Q1 OpenAlex 9.5%
- 2006 Treatment results of 84 patients with nasopharyngeal carcinoma in childhood YÖKSİS SJR Q1 JCR Q2 OpenAlex 75.1%
- 2005 Assessment of quality of life of nasopharyngeal carcinoma patients with EORTC QLQ C30 and H N 35 modules YÖKSİS SJR Q1 JCR Q1 OpenAlex 86.0%
- 2005 Induction chemotherapy with cisplatin and 5 fluorouracil followed by chemoradiotherapy or radiotherapy alone in the treatment of locoregionally advanced resectable cancers of the larynx and hypopharynx Results of single center study of 45 patients YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 92.4%
- 2005 Treatment Results of 165 Pediatric Patients with Non Metastatic Nasopharyngeal Carcinoma A Rare Cancer Network Study YÖKSİS SJR Q1 JCR Q1 OpenAlex 11.6%
- 2004 Salvage Ifosfamide Doxorubicin Chemotherapy in Patients with Recurrent Nasopharyngeal Carcinoma Pretreated with Cisplatin Based Chemotherapy YÖKSİS SJR Q2 JCR Q4 OpenAlex 69.1%
- 2004 Assessment of quality life of nasopharyngeal carcinoma patients with EORTC QLQ C30 and H N 30 Turkish oncology group head and neck working party study YÖKSİS SJR Q1 JCR Q1 OpenAlex 47.2%